Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.

被引：0
|
作者：
Karanth, M
Harvey, C
Chakrabarti, S
Holder, K
McConkey, CC
McDonald, D
Lovell, RA
Fegan, CD
Milligan, DW
机构：
[1] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
[2] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, Birmingham Ctr, Natl Blood Serv, Birmingham B15 2TT, W Midlands, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3261
引用
收藏
页码：826A / 826A
页数：1
相关论文
共 50 条
  • [1] Increased age is correlated with a reduced PBSC mobilisation only after "g-csf alone" but not after "chemo plus g-csf"
    Milone, G
    Poidomani, M
    Tornello, A
    Murgano, P
    Coppoletta, S
    Pinto, V
    Mercurio, S
    Consoli, U
    Giustolisi, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S105 - S105
  • [2] Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma
    Chua, Chong Chyn
    Lim, Hui Yin
    Chai, Khai Li
    Ong, Jeremy
    Sim, Shirlene
    Wood, Colin
    Dickinson, Michael
    Campbell, Philip
    Hempton, Jennifer
    King, Hayley
    Dowsing, Claire
    Bergin, Krystal
    Muir, Sharon
    Gibbs, Simon
    Grigg, Andrew
    BONE MARROW TRANSPLANTATION, 2018, 53 (09) : 1116 - 1123
  • [3] Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma
    Chong Chyn Chua
    Hui Yin Lim
    Khai Li Chai
    Jeremy Ong
    Shirlene Sim
    Colin Wood
    Michael Dickinson
    Philip Campbell
    Jennifer Hempton
    Hayley King
    Claire Dowsing
    Krystal Bergin
    Sharon Muir
    Simon Gibbs
    Andrew Grigg
    Bone Marrow Transplantation, 2018, 53 : 1116 - 1123
  • [4] The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma
    Rees, Matthew J.
    Panigrahi, Ashish
    Harrison, Simon J.
    Spencer, Andrew
    Khong, Tiffany
    Gibbs, Simon
    Hocking, Jay
    Grigg, Andrew
    Zantomio, Daniela
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1001 - 1003
  • [5] The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma
    Matthew J. Rees
    Ashish Panigrahi
    Simon J. Harrison
    Andrew Spencer
    Tiffany Khong
    Simon Gibbs
    Jay Hocking
    Andrew Grigg
    Daniela Zantomio
    Bone Marrow Transplantation, 2022, 57 : 1001 - 1003
  • [6] Allogeneic transplantation of peripheral blood stem cells (PBSC) mobilized in normal donors with rHuEpo and G-CSF compared with G-CSF alone.
    Beguin, Y
    Baudoux, E
    Hermanne, JP
    Salmon, JP
    Pereira, M
    Debouge, MH
    Sondag, D
    Fillet, G
    BLOOD, 1997, 90 (10) : 4199 - 4199
  • [7] A Retrospective Single Center Comparison of Cyclophosphamide Plus G-CSF Versus G-CSF Alone for Peripheral Blood Stem Cell (PBSC) Mobilisation Following First Line Therapy in Patients with Multiple Myeloma
    Whitmill, Richard S.
    Lewis, David J.
    Sutton, David John
    Khawaja, Jahanzeb
    Mayer, Georgina
    Paneesha, Shankaranarayana
    Nikolousis, Emmanouil
    Kishore, Bhuvan
    BLOOD, 2015, 126 (23)
  • [8] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [9] Peripheral blood stem cell (PBSC) mobilization in breast cancer patients:: Chemotherapy plus G-CSF versus G-CSF alone
    Varo, MJ
    Azaceta, G
    Mayordomo, JI
    Tres, A
    Olave, T
    Moreno, JA
    Domingo, JM
    Gutiérrez, M
    Palomera, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 74 - 74
  • [10] Successful peripheral blood mobilization of CD34 progenitor cells by cyclophosphamide, paclitaxel and G-CSF after failure with G-CSF alone.
    Dansey, R
    Klein, J
    Karanes, C
    Akhtar, A
    Cassells, L
    Peters, WP
    Baynes, RD
    BLOOD, 1997, 90 (10) : 428 - 428
12345